UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Population-based analysis of invasive fungal infections, France, 2001-2010

Emerging infectious diseases, 2014-07, Vol.20 (7), p.1149-1169

2014

Link zum Volltext

Verfügbarkeit prüfen

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients

Journal of antimicrobial chemotherapy, 2016-09, Vol.71 (9), p.2379-2385

2016

Link zum Volltext

Verfügbarkeit prüfen

Increasing Pneumocystis pneumonia, England, UK, 2000-2010

Emerging infectious diseases, 2013-03, Vol.19 (3), p.386-392

2013

Link zum Volltext

Verfügbarkeit prüfen

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis

Bone marrow transplantation (Basingstoke), 2016-04, Vol.51 (4), p.573-580

2016

Link zum Volltext

Verfügbarkeit prüfen

Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation

Pharmacological research, 2018-08, Vol.134, p.61-67

2018

Link zum Volltext

Verfügbarkeit prüfen

Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients

International journal of infectious diseases, 2016-05, Vol.46, p.11-17

2016

Link zum Volltext

Verfügbarkeit prüfen

Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience

Clinical and experimental rheumatology, 2017-07, Vol.35 (4), p.671

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America

Rheumatology (Oxford, England), 2021-02, Vol.60 (2), p.829-836

2021

Link zum Volltext

Verfügbarkeit prüfen

High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia

International journal of infectious diseases, 2019-11, Vol.88, p.141-148

2019

Link zum Volltext

Verfügbarkeit prüfen

UK paediatric oncology Pneumocystis jirovecii pneumonia surveillance study

Archives of disease in childhood, 2021-10, Vol.106 (10), p.994

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study

BMC infectious diseases, 2017-06, Vol.17 (1), p.392-392, Article 392

2017

Link zum Volltext

Verfügbarkeit prüfen

Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death

PloS one, 2015-09, Vol.10 (9), p.e0139144-e0139144

2015

Link zum Volltext

Verfügbarkeit prüfen

Pneumocystis jiroveci pneumonia in immunocompromised patients: Delayed diagnosis and poor outcomes in non-HIV-infected individuals

Journal of microbiology, immunology and infection, 2014-02, Vol.47 (1), p.42-47

2014

Link zum Volltext

Verfügbarkeit prüfen

Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients

Respiratory research, 2019-09, Vol.20 (1), p.213-213, Article 213

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Significance of Quantifying Pneumocystis jirovecii DNA by Using Real-Time PCR in Bronchoalveolar Lavage Fluid from Immunocompromised Patients

Journal of Clinical Microbiology, 2012-02, Vol.50 (2), p.227-231

2012

Link zum Volltext

Verfügbarkeit prüfen

Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China

PloS one, 2014-07, Vol.9 (7), p.e101943-e101943

2014

Link zum Volltext

Verfügbarkeit prüfen

The association between Cytomegalovirus co‐infection with Pneumocystis pneumonia and mortality in immunocompromised non‐HIV patients

The clinical respiratory journal, 2018-11, Vol.12 (11), p.2590-2597

2018

Link zum Volltext

Verfügbarkeit prüfen

Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons—San Francisco, 1981-2012

The Journal of infectious diseases, 2015-11, Vol.212 (9), p.1366-1375

2015

Link zum Volltext

Verfügbarkeit prüfen

Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials

Mayo Clinic proceedings, 2007-09, Vol.82 (9), p.1052-1059

2007

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study

Annals of clinical microbiology and antimicrobials, 2021-11, Vol.20 (1), p.78-78, Article 78

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave

Microbiology spectrum, 2021-10, Vol.9 (2), p.e0113821-e0113821

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases

PloS one, 2019-03, Vol.14 (3), p.e0214324-e0214324

2019

Link zum Volltext

Verfügbarkeit prüfen

Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia

Respiratory research, 2013-08, Vol.14 (1), p.87-87

2013

Link zum Volltext

Verfügbarkeit prüfen

Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia

Clinical microbiology and infection, 2012-05, Vol.18 (5), p.E122-E127

2012

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia

Clinical microbiology and infection, 2015-11, Vol.21 (11), p.1018.e9-1018.e15

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 882

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(766)
Mit Volltextzugriff
(646)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(761)
Science & Technology
(696)
Life Sciences & Biomedicine
(674)
Male
(514)
Female
(484)
Adult
(428)
Pneumonia, Pneumocystis - Mortality
(407)
Aids/hiv
(360)
Mortality
(356)
Middle Aged
(348)
Pneumonia
(296)
Biological And Medical Sciences
(287)
Infectious Diseases
(285)
Medical Sciences
(284)
Human Immunodeficiency Virus
(265)
Hiv
(253)
Pneumocystis Carinii
(224)
Retrospective Studies
(217)
Aids
(214)
Risk Factors
(197)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Population-based analysis of invasive fungal infections, France, 2001-2010

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients

Increasing Pneumocystis pneumonia, England, UK, 2000-2010

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis

Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation

Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients

Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience

Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America

High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia

UK paediatric oncology Pneumocystis jirovecii pneumonia surveillance study

Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study

Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death

Pneumocystis jiroveci pneumonia in immunocompromised patients: Delayed diagnosis and poor outcomes in non-HIV-infected individuals

Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients

Clinical Significance of Quantifying Pneumocystis jirovecii DNA by Using Real-Time PCR in Bronchoalveolar Lavage Fluid from Immunocompromised Patients

Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China

The association between Cytomegalovirus co‐infection with Pneumocystis pneumonia and mortality in immunocompromised non‐HIV patients

Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons—San Francisco, 1981-2012

Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials

Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study

COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave

Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases

Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia

Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia

High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia

Suchergebnisse filtern